InsidersTradesSigma
Follow the Bacil Pharma stock price and the full management transaction log of the company, a listed issuer based in India. Shares are quoted on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €176.5m. The latest transaction was reported on 16 July 2026 (Disposal). Among the most active insiders: Manubhai Shah. All data is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Bacil Pharma is a pharmaceutical company operating in the XBOM market. It focuses on the development and commercialization of innovative pharmaceutical products.